Functional Antigen‐Specific CD8 T SCM Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection
European Journal of Immunology · 2025
DOI: 10.1002/eji.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Yanran Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Viral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Hepacivirus, Immunologic Memory, Memory T Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian National Health and Medical Research Council (NHMRC), NHMRC Career Development Fellowships, NHMRC Practitioner Fellowship.
Abstract (Originalsprache)
Natural clearance of hepatitis C virus (HCV) infection occurs in about 25% of primary infections, but offers only partial protective immunity against re‐infections. This study hypothesised that long‐lived polyfunctional HCV‐specific CD8+ memory stem T cells (T SCM ) contribute to protective immunity in rare super‐clearer subjects who repeatedly clear viraemia. Six super‐clearers and four clearer‐chronic subjects who resolved a primary infection but subsequently developed chronic infection were studied at multiple timepoints. The T SCM population (CCR7+CD45RA+CD95+) was bulk sorted, labelled with CellTrace Violet (CTV), and stimulated in vitro for five days with cognate HCV peptide, IL‐2/IL‐15, and autologous PBMCs. Functionality of the expanded HCV‐specific T SCM was assessed via the proliferation, multi‐potency, and stemness indices. Total HCV‐specific CD8+ T cells from super‐clearers exhibited enhanced proliferative recall capability compared with clearer‐chronics. Furthermore, super‐clearers exhibited higher HCV‐T SCM frequencies post‐expansion (22.35 ± 34.35 vs. 2.41 ± 9.83; p = 0.0066). Notably, HCV‐T SCM in clearer‐chronics had ‘stemness’ indices of zero in samples before the re‐infection (i.e., no ability to generate T SCM as progeny), whereas super‐clearers consistently retained this key functional property. These findings suggest that the maintenance of self‐renewing HCV‐specific T SCM may underpin long‐term protective immunity against re‐infection and could inform vaccine design strategies targeting durable cellular memory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Viral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia.
- School of Biomedical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.
- Burnet Institute, Melbourne, VIC, Australia.
- Department of Microbiology, Monash University, Clayton, VIC, Australia.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Förderung
- Australian National Health and Medical Research Council (NHMRC)
- NHMRC Career Development Fellowships
- NHMRC Practitioner Fellowship
Zitieren
APA
Zhao, Y., Keoshkerian, E., Li, H., Sacks-David, R., Boo, I., Dietze, P., Hellard, M., Drummer, H., Luciani, F., Bull, R. A., & Lloyd, A. R. (2025). Functional Antigen‐Specific CD8 T SCM Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection. European Journal of Immunology. https://doi.org/10.1002/eji.70098
Vancouver
Zhao Y, Keoshkerian E, Li H, Sacks-David R, Boo I, Dietze P, et al. Functional Antigen‐Specific CD8 T SCM Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection. European Journal of Immunology. 2025. doi:10.1002/eji.70098
BibTeX
@article{Zhao2025,
author = {Zhao, Yanran and Keoshkerian, Elizabeth and Li, Hui and Sacks-David, Rachel and Boo, Irene and Dietze, Paul and Hellard, Margaret and Drummer, Heidi and Luciani, Fabio and Bull, Rowena A and Lloyd, Andrew R},
title = {Functional Antigen‐Specific CD8 T SCM Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70098}
}
EUVIMED